Armistice Capital »

Autolus Therapeutics Plc spon ads shares owned by Armistice Capital

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $30M 4.7M 6.38
2023-09-30 $16M 6.9M 2.33
2023-06-30 $17M 7.3M 2.38
2023-03-31 $18M 9.7M 1.84
2022-12-31 $19M 10M 1.90

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
FMR
Polygon Management
Cormorant Asset Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Armistice Capital
Frazier Life Sciences Management
Perceptive Advisors
BlackRock
Deerfield Management Company
Adage Capital Partners GP
Commodore Capital
Perpetual

View all funds holding Autolus Therapeutics Plc spon ads